Genetic Testing Services Global Market Report 2025
상품코드:1825744
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전자 검사 서비스 시장 규모는 향후 몇 년간 급격한 성장이 예상됩니다. 2029년에는 CAGR 10.3%로 316억 4,000만 달러로 성장할 것입니다. 예측 기간의 성장은 비침습적 산전 검사(NIPT)의 수요 확대, 약리유전체학의 부상, 예방적 헬스케어에 대한 관심 증가, DTC(Direct-to-Consumer) 검사의 증가, 희귀질환 및 맞춤치료에 대한 관심 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 인공지능(AI)과 머신러닝, 사용자 친화적인 검사 키트 및 온라인 플랫폼의 발전, 차세대 시퀀싱, 마이크로어레이 분석, 중합효소 연쇄 반응(PCR), 첨단 헬스케어 인프라 등이 있습니다.
향후 5년간 10.3%의 성장률 전망은 지난번 예측보다 0.9% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스웨덴과 호주에서 개발된 전 엑솜 시퀀싱 및 약리유전체 분석 서비스 가격을 급등시켜 개인별 맞춤 치료 계획의 지연과 전문 연구소의 비용 상승을 가져와 미국의 정밀의료를 저해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
유전성 질환의 유병률 증가는 향후 유전자 검사 서비스 시장의 성장을 촉진할 것으로 예상됩니다. 유전성 질환은 개인의 DNA 이상에 기인하여 다양한 신체적 또는 발달적 이상을 초래합니다. 유전자 질환의 유병률 증가 요인으로는 인지도 향상, 진단 방법의 개선, 유전자 검사 이니셔티브의 확대, 특정 집단의 근친상간 발생률 증가 등을 들 수 있습니다. 유전자 검사 서비스는 유전성 질환의 진단, 예후 예측, 치료 전략 결정에 매우 중요한 역할을 하고 있으며, 유전 정보에 기반한 맞춤 의료 및 가족계획 결정을 촉진하고 있습니다. 예를 들어, 세계보건기구(WHO)가 2023년 2월에 보고한 바와 같이, 선천성 질환은 매년 전 세계적으로 출생 후 28일 이내에 약 24만 명의 영아가 사망하는 원인이 되고 있습니다. 또한 미국 질병예방통제센터(CDC)에 따르면 미국에서는 연간 약 6,000명의 다운증후군 아이가 태어나고 있으며, 이는 약 700명당 1명꼴로 태어나는 비율입니다. 따라서 유전성 질환의 유병률 증가는 유전자 검사 서비스 시장 성장의 원동력이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 유전자 검사 서비스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 유전자 검사 서비스 시장 : 성장률 분석
세계의 유전자 검사 서비스 시장 실적 : 규모와 성장, 2019-2024
세계의 유전자 검사 서비스 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 유전자 검사 서비스 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 유전자 검사 서비스 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
예측 테스트
캐리어 테스트
산전 검사
신생아 스크리닝
기타 유형
세계의 유전자 검사 서비스 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
암 질환
대사성 질환
심혈관질환
기타 질병
세계의 유전자 검사 서비스 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단 검사실
병원과 진료소
학술기관 및 연구 센터
기타 최종사용자
세계의 유전자 검사 서비스 시장 : 하위 세분화 예측 테스트(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
암소인 검사
심장병 리스크 검사
신경질환 리스크 검사
기타 예측 테스트
세계의 유전자 검사 서비스 시장 : 하위 세분화 캐리어 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단일 유전질환 보인자 스크리닝
다인자 질환 캐리어 스크리닝
유전성 질환 보인자 스크리닝
기타 캐리어 검사
세계의 유전자 검사 서비스 시장 : 하위 세분화 산전 검사 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
비침습적 산전 검사(NIPT)
양수천자
융모막융모 채취(CVS)
초음파와 조합한 유전자 검사
기타 산전 검사
세계의 유전자 검사 서비스 시장 : 하위 세분화 신생아 스크리닝(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
대사이상 스크리닝
유전성 질환 스크리닝
난청 스크리닝
내분비질환 스크리닝
기타 신생아 스크리닝 검사
세계의 유전자 검사 서비스 시장 : 하위 세분화 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
약물유전학적 검사
법의학적 유전자 검사
조상과 유전자 계보 검사
친자확인
기타 전문적인 유전자 검사
제7장 지역별·국가별 분석
세계의 유전자 검사 서비스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 유전자 검사 서비스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전자 검사 서비스 시장 : 경쟁 구도
유전자 검사 서비스 시장 : 기업 개요
F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Laboratory Corporation of America Holdings(LabCorp) Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Quest Diagnostics Incorporated
Eurofins Scientific SE
SGS SA
Agilent Technologies
Hologic Inc.
Illumina Inc.
PerkinElmer Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Natera Inc.
Myriad Genetics Inc.
BGI Genomics Co. Ltd.
Invitae Corporation
NeoGenomics Laboratories Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
유전자 검사 서비스 시장 2029 : 새로운 기회를 제공하는 국가
유전자 검사 서비스 시장 2029 : 새로운 기회를 제공하는 부문
유전자 검사 서비스 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Genetic testing services involve the analysis of an individual's DNA to detect variations or mutations that may indicate disease susceptibility, ancestry information, or other genetic characteristics. These services typically provide insights into potential health risks, ancestral origins, and personalized recommendations based on genetic predispositions, aiding in informed medical decisions and lifestyle choices.
The primary categories of genetic testing services include predictive testing, carrier testing, prenatal testing, newborn screening, and other specialized tests. Predictive testing assesses an individual's risk of developing specific conditions such as cancer, metabolic disorders, cardiovascular diseases, and others. These services are utilized by a variety of stakeholders including diagnostic laboratories, hospitals and clinics, academic institutions, research centers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The genetic testing services market research report is one of a series of new reports from The Business Research Company that provides genetic testing services market statistics, including genetic testing services industry global market size, regional shares, competitors with a genetic testing services market share, detailed genetic testing services market segments, market trends and opportunities, and any further data you may need to thrive in the genetic testing services industry. This genetic testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genetic testing services market size has grown rapidly in recent years. It will grow from $19.19 billion in 2024 to $21.36 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing demand for personalized and precision medicine, growing prevalence of genetic disorders, high demand for prenatal testing during pregnancy, increasing population, and increased awareness and education.
The genetic testing services market size is expected to see rapid growth in the next few years. It will grow to $31.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to the growing demand for non-invasive prenatal testing (NIPT), the rise of pharmacogenomics, the growing focus on preventive healthcare, increasing direct-to-consumer (DTC) testing, and the focus on rare diseases and personalized therapies. Major trends in the forecast period include artificial intelligence (AI) and machine learning, advancements in user-friendly testing kits and online platforms, next-generation sequencing, microarray analysis, polymerase chain reaction (PCR), and advanced healthcare infrastructure.
The forecast of 10.3% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. precision medicine by inflating prices of whole-exome sequencing and pharmacogenomic analysis services developed in Sweden and Australia, resulting in delayed personalized treatment plans and higher specialty lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of genetic disorders is anticipated to drive the growth of the genetic testing services market in the future. Genetic disorders, stemming from abnormalities in an individual's DNA, result in various physical or developmental abnormalities. Factors contributing to the increased prevalence of genetic disorders include heightened awareness, improved diagnostic methods, expanded genetic screening initiatives, and a growing incidence of consanguineous marriages in certain populations. Genetic testing services play a pivotal role in diagnosing, prognosing, and determining treatment strategies for individuals with genetic disorders, facilitating personalized medical care and family planning decisions based on genetic information. For example, as reported by the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 infant deaths globally within the first 28 days of birth each year. Additionally, according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome in the United States annually, translating to about 1 in every 700 births. Hence, the escalating prevalence of genetic disorders is a driving force behind the growth of the genetic testing services market.
Key players in the genetic testing services market are concentrating on advancing technological solutions, such as cancer screening tests, to enhance precision, broaden testing capabilities, and improve patient outcomes overall. Cancer screening tests are routine examinations conducted on asymptomatic individuals to detect early signs of cancer. These tests aim to identify cancer or precancerous conditions before symptoms manifest, enabling more effective treatment interventions. For instance, in June 2022, Prenetics Group Limited introduced ColoClear, a non-invasive stool DNA test in Hong Kong, leveraging highly sensitive screening methods to detect early indications of colorectal cancer. Combining advanced stool DNA technology with fecal immunochemical testing (FIT), ColoClear offers a convenient and efficient alternative to colonoscopy. Clinical studies have demonstrated ColoClear's sensitivity of 96% in colorectal cancer detection and 64% in advanced adenoma detection.
In November 2022, Myriad Genetics Inc. bolstered its presence in women's health and oncology testing by acquiring Gateway Genomics for $67.5 million. This strategic move expands Myriad's portfolio of comprehensive and personalized genetic testing solutions for patients. Gateway Genomics LLC, a US-based genetics company specializing in genetic testing services, complements Myriad's capabilities in the field.
Major companies operating in the genetic testing services market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc, 23andMe Holding Co, Berry Genomics Co. Ltd, Pacific Biosciences of California Inc, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, Veritas Genetics
North America was the largest region in the genetic testing services market in 2024. The regions covered in the genetic testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genetic testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genetic testing services market consists of revenues earned by entities by providing services such as newborn screening, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, predictive and presymptomatic testing, ancestry testing, nutrigenomics testing, and forensic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genetic Testing Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genetic testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genetic testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic testing services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Predictive Testing; Carrier Testing; Prenatal Testing; Newborn Screening; Other Types
2) By Disease: Cancer Disease; Metabolic Disease; Cardiovascular Disease; Other Diseases
3) By End User: Diagnostic Laboratories; Hospitals And Clinics; Academic Institutes And Research Centers; Other End Users
Subsegments:
1) By Predictive Testing: Cancer Predisposition Testing; Heart Disease Risk Testing; Neurological Disorder Risk Testing; Other Predictive Tests
2) By Carrier Testing: Carrier Screening For Single-Gene Disorders; Carrier Screening For Multifactorial Conditions; Carrier Screening For Inherited Genetic Conditions; Other Carrier Tests
3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis; Chorionic Villus Sampling (CVS); Ultrasound-Combined Genetic Testing; Other Prenatal Tests
4) By Newborn Screening: Metabolic Disorder Screening; Genetic Disorder Screening; Hearing Loss Screening; Endocrine Disorder Screening; Other Newborn Screening Tests
5) By Other Types: Pharmacogenetic Testing; Forensic Genetic Testing; Ancestry And Genetic Genealogy Testing; Paternity Testing; Other Specialized Genetic Tests
3. Genetic Testing Services Market Trends And Strategies
4. Genetic Testing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Genetic Testing Services Growth Analysis And Strategic Analysis Framework
5.1. Global Genetic Testing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genetic Testing Services Market Growth Rate Analysis
5.4. Global Genetic Testing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genetic Testing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genetic Testing Services Total Addressable Market (TAM)
6. Genetic Testing Services Market Segmentation
6.1. Global Genetic Testing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Testing
Carrier Testing
Prenatal Testing
Newborn Screening
Other Types
6.2. Global Genetic Testing Services Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Disease
Metabolic Disease
Cardiovascular Disease
Other Diseases
6.3. Global Genetic Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Laboratories
Hospitals And Clinics
Academic Institutes And Research Centers
Other End Users
6.4. Global Genetic Testing Services Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Predisposition Testing
Heart Disease Risk Testing
Neurological Disorder Risk Testing
Other Predictive Tests
6.5. Global Genetic Testing Services Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carrier Screening For Single-Gene Disorders
Carrier Screening For Multifactorial Conditions
Carrier Screening For Inherited Genetic Conditions
Other Carrier Tests
6.6. Global Genetic Testing Services Market, Sub-Segmentation Of Prenatal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Invasive Prenatal Testing (NIPT)
Amniocentesis
Chorionic Villus Sampling (CVS)
Ultrasound-Combined Genetic Testing
Other Prenatal Tests
6.7. Global Genetic Testing Services Market, Sub-Segmentation Of Newborn Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metabolic Disorder Screening
Genetic Disorder Screening
Hearing Loss Screening
Endocrine Disorder Screening
Other Newborn Screening Tests
6.8. Global Genetic Testing Services Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacogenetic Testing
Forensic Genetic Testing
Ancestry And Genetic Genealogy Testing
Paternity Testing
Other Specialized Genetic Tests
7. Genetic Testing Services Market Regional And Country Analysis
7.1. Global Genetic Testing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genetic Testing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
